These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36463349)

  • 1. Platelets in COVID-19 disease: friend, foe, or both?
    Smęda M; Hosseinzadeh Maleki E; Pełesz A; Chłopicki S
    Pharmacol Rep; 2022 Dec; 74(6):1182-1197. PubMed ID: 36463349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors.
    Xiang M; Wu X; Jing H; Liu L; Wang C; Wang Y; Novakovic VA; Shi J
    Front Immunol; 2022; 13():955654. PubMed ID: 36248790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime?
    O'Kennedy N; Duttaroy AK
    Med Hypotheses; 2021 Feb; 147():110480. PubMed ID: 33421690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets in rheumatic diseases: friend or foe?
    Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD
    Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stimulated platelets in COVID-19 thrombosis: Role of alpha7 nicotinic acetylcholine receptor.
    Jankauskaite L; Malinauskas M; Snipaitiene A
    Front Cardiovasc Med; 2022; 9():1037369. PubMed ID: 36312286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Uzun G; Pelzl L; Singh A; Bakchoul T
    Front Immunol; 2022; 13():837629. PubMed ID: 35273612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications.
    Schrottmaier WC; Pirabe A; Pereyra D; Heber S; Hackl H; Schmuckenschlager A; Brunnthaler L; Santol J; Kammerer K; Oosterlee J; Pawelka E; Treiber SM; Khan AO; Pugh M; Traugott MT; Schörgenhofer C; Seitz T; Karolyi M; Jilma B; Rayes J; Zoufaly A; Assinger A
    Front Cardiovasc Med; 2021; 8():802566. PubMed ID: 35141292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation.
    Philippe A; Chocron R; Bonnet G; Yatim N; Sutter W; Hadjadj J; Weizman O; Guerin CL; Mirault T; Fauvel C; Hauw-Berlemont C; Samama CM; Terrier B; Planquette B; Waldmann V; Fontenay M; Sanchez O; Diehl JL; Gaussem P; Cohen A; Gendron N; Smadja DM
    Arch Cardiovasc Dis; 2023 Apr; 116(4):183-191. PubMed ID: 36858909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current state and novel approaches of antiplatelet therapy.
    Metharom P; Berndt MC; Baker RI; Andrews RK
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1327-38. PubMed ID: 25838432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein VI - novel target in antiplatelet medication.
    Borst O; Gawaz M
    Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.
    Coccheri S
    Drugs; 2010 May; 70(7):887-908. PubMed ID: 20426498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets in liver transplantation: friend or foe?
    Pereboom IT; Lisman T; Porte RJ
    Liver Transpl; 2008 Jul; 14(7):923-31. PubMed ID: 18581510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets as therapeutic targets to prevent atherosclerosis.
    Nording H; Baron L; Langer HF
    Atherosclerosis; 2020 Aug; 307():97-108. PubMed ID: 32653088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
    Tafazoli A; Anil Kumar S; Othman M
    Platelets; 2022 Jan; 33(1):48-53. PubMed ID: 34847829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
    Barale C; Melchionda E; Morotti A; Russo I
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.
    Passacquale G; Ferro A
    Br J Clin Pharmacol; 2011 Oct; 72(4):604-18. PubMed ID: 21223359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of platelets in inflammatory and thrombotic reactions in the elderly.].
    Osadchuk AM; Davydkin IL; Zolotovskaia IA
    Adv Gerontol; 2021; 34(1):76-83. PubMed ID: 33993665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.